Home > Antibodies

Classified by application

All Products

Signaling Pathways

Research Areas


Nature products




Raw Materials



Chemical Structure Cat. No. Product Name CAS No.
Rituximab Chemical Structure
BCP20918 Rituximab 174722-31-7
Rituximab is a chimeric monoclonal antibody against the protein CD20, which is primarily found on the surface of immune system B cells.
Avastin Chemical Structure
BCP07998 Avastin 216974-75-3
Denosumab Chemical Structure
BCP05825 Denosumab 615258-40-7
Denosumab is a human monoclonal antibody for the treatment of osteoporosis, treatment-induced bone loss, metastases to bone, and giant cell tumor of bone.
Trastuzumab Chemical Structure
BCP05130 Trastuzumab 180288-69-1
Trastuzumab is a monoclonal antibody used to treat breast cancer.
Cetuximab Chemical Structure
BCP02158 Cetuximab 205923-56-4
Cetuximab is an epidermal growth factor receptor (EGFR) inhibitor used for the treatment of metastatic colorectal cancer, metastatic non-small cell lung cancer and head and neck cancer.
Ofatumumab Chemical Structure
BCP28064 Ofatumumab 679818-59-8
Ofatumumab is a fully human monoclonal antibody (for the CD20 protein) which appears to inhibit early-stage B lymphocyte activation.
Ranibizumab Chemical Structure
BCP12860 Ranibizumab 347396-82-1
Ranibizumab is a monoclonal antibody fragment (Fab) created from the same parent mouse antibody as bevacizumab.
Nivolumab Chemical Structure
BCP28580 Nivolumab 946414-94-4
Nivolumab, marketed as Opdivo, is a humanized IgG4 anti-PD-1 monoclonal antibody used to treat cancer.
Solanezumab Chemical Structure
BCP13788 Solanezumab 955085-14-0
Solanezumab is a monoclonal antibody being investigated by Eli Lilly as a neuroprotector for patients with Alzheimer's disease.
Atezolizumab Chemical Structure
BCP18055 Atezolizumab 1380723-44-3
Atezolizumab is a fully humanized, engineered monoclonal antibody of IgG1 isotype against the protein programmed cell death-ligand 1 (PD-L1).
123下一页共 24 条记录 1 / 3 页